BIRCROFT PRIVATE LTD

Company number 07109598 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: BIRCROFT PRIVATE LTD


1. Financial Health Score: D+

Explanation: The company exhibits chronic symptoms of financial deterioration. While not yet in acute distress, the patient has suffered significant erosion of financial vitality over the past six years, with net assets declining by approximately 87% from their 2019 peak. The current liquidity position provides a thin buffer, but the underlying trend of losses and increasing creditor pressure suggests the business is in a fragile state requiring urgent attention.


2. Key Vital Signs

Net Assets (Financial "Blood Pressure")

Year Net Assets Year-on-Year Change
2019 £204,192
2020 £162,336 -20.5%
2021 £35,916 -77.9%
2022 £108,612 +202.4%
2023 £190,386 +75.3%
2024 £49,414 -74.0%
2025 £26,177 -47.0%

Interpretation: This is the most alarming vital sign. The company's financial reserves have been haemorrhaging. The volatile swings suggest the business is heavily influenced by investment valuations and director-related transactions rather than stable operational performance. The 2025 position of £26,177 represents a critically low equity base for a company with £178,331 in current liabilities.

Current Ratio (Liquidity "Pulse Rate")

  • Current Assets: £201,173
  • Current Liabilities: £178,331
  • Current Ratio: 1.13

Interpretation: A current ratio of 1.13 is the financial equivalent of a borderline pulse — barely sufficient. For every £1 owed within the next year, the company only has £1.13 to cover it. This leaves virtually no margin for unexpected expenses or revenue delays. A healthy business typically maintains a ratio of 1.5 or above.

Cash Position (Financial "Oxygen Supply")

Year Cash Cash as % of Current Assets
2024 £78,207 55%
2025 £173,400 86%

Interpretation: At first glance, the significant increase in cash appears healthy. However, context is critical — this cash build-up coincides with substantial director loan advances (over £212,000 advanced in the year) and may represent funding injections rather than operational cash generation. The company appears to be surviving on financial life support from its directors rather than generating sustainable cash flows.

Retained Earnings (Financial "Muscle Mass")

  • 2024: £49,312
  • 2025: £26,075
  • Decline: £23,237 (47% reduction)

Interpretation: The company has burned through nearly half its accumulated retained earnings in a single year. This indicates the business is operating at a loss — consuming its own financial muscle to survive.

Investment Write-Off (Financial "Organ Failure")

  • 2024: Investments valued at £40,000
  • 2025: Investments written down to £0 (full provision of £40,000)

Interpretation: The complete write-off of a £40,000 investment represents a significant financial event. This suggests either a total loss on the investment or recognition that recovery is impossible. This is equivalent to the loss of a functioning organ in the business structure.


3. Diagnosis

Primary Diagnosis: Chronic Financial Deterioration with Acute Episode in FY2025

The financial data reveals a business that has been in long-term decline since 2019, with a particularly severe episode in the year ended 31 January 2025. The key symptoms include:

1. Loss-Making Operations The reduction in retained earnings from £49,312 to £26,075 indicates a loss of approximately £23,237 for the year (before accounting for the investment write-off and other movements). Combined with the £40,000 investment provision, total comprehensive losses likely exceeded £63,000.

2. Increasing Creditor Pressure - Taxation and social security liabilities nearly doubled from £46,423 to £87,613 - Other creditors increased from £75,452 to £86,551 - Total current liabilities rose by 35% from £131,875 to £178,331

This pattern suggests the company is stretching its payment terms and accumulating obligations faster than it can meet them — a classic symptom of cash flow distress.

3. Director Dependency The company owes its directors approximately £63,073 in aggregate (combining all three director loan balances). Additionally, £16,052 is owed to non-director shareholders. This means roughly £79,125 (44% of current liabilities) is owed to the company's own owners. While this provides flexible funding, it also indicates the business cannot generate sufficient revenue to fund its own operations.

4. Revenue Concerns Trade debtors declined from £40,991 to £24,000, which could indicate either: - Decreasing revenue (fewer fees being earned) - Faster collection (positive, but unlikely given cash pressures) - A shrinking client base

Given the overall financial deterioration, declining trade debtors most likely signals contracting revenue.

5. Volatile Financial History The dramatic swings in net assets (from £23,375 in 2017 to £204,192 in 2019, then back down to £26,177 in 2025) suggest the business model is inherently unstable or heavily dependent on unpredictable investment returns.

Secondary Conditions

  • Thin Capitalisation: With only £26,177 in net assets supporting a business with £204,508 in total assets, the company is significantly under-capitalised (gearing ratio of approximately 6.8:1 liabilities to equity)
  • Tax Liability Accumulation: The growing tax creditor may indicate difficulties in meeting obligations to HMRC, which can trigger enforcement action
  • Investment Risk: The complete write-off of the £40,000 investment raises questions about the directors' investment judgment

4. Prognosis

Short-term (6-12 months): Guarded

The company can continue to trade in the immediate term, primarily because: - It has £173,400 in cash - Director loans provide flexible creditor arrangements - Filing obligations are being met

However, the thin current ratio and declining equity mean any unexpected liability or revenue shortfall could push the company into insolvency territory.

Medium-term (1-3 years): Concerning

Without significant operational improvement, the company faces: - Continued erosion of net assets - Potential difficulty in meeting tax obligations - Risk of director loan withdrawal creating a liquidity crisis - Possible breach of minimum capital requirements if losses continue


5. Recommendations

Urgent Actions (Within 30 Days)

  1. Cash Flow Stabilisation - Prepare a detailed 13-week cash flow forecast to identify potential shortfalls - Prioritise HMRC payments to avoid enforcement action and associated penalties - Negotiate time-to-pay arrangements with HMRC if necessary (the "Time to Pay" scheme)

  2. Creditor Management - Review the £86,551 in "other creditors" — identify what is owed and to whom - Agree payment terms with non-director creditors to avoid pressure - Formally document director loan repayment expectations

Medium-Term Actions (1-6 Months)

  1. Revenue Recovery Plan - Conduct a thorough review of the fee income pipeline and client retention - The decline in trade debtors suggests a shrinking revenue base — this must be reversed - Consider whether the current business model (financial intermediation/advice) is sustainable at current scale

  2. Investment Policy Review - The £40,000 investment write-off demands a post-mortem — what went wrong and how can similar losses be prevented? - Establish clear investment criteria and risk limits before committing company funds

  3. Capital Restructuring - Consider converting some director loans to equity to improve the balance sheet appearance and reduce gearing - Explore whether non-director shareholder loans (£16,052) could be restructured

Long-Term Actions (6-18 Months)

  1. Strategic Review - With only 4 employees and declining net assets, consider whether the business has a viable long-term future in its current form - Evaluate options: growth investment, merger, managed wind-down, or pivot to a more profitable service offering

  2. Governance Enhancement - Given the significant director loan activity (over £212,000 advanced in the year), implement formal loan policies and board approval processes - Consider appointing an independent advisor to review related-party transactions

  3. Financial Monitoring - Establish monthly management accounts with variance analysis - Set key performance indicators (KPIs) including minimum current ratio target of 1.5:1 - Implement quarterly financial health checks


Summary of Key Metrics

Metric 2025 2024 Trend Health
Net Assets £26,177 £49,414 ▼▼ ⚠️ Critical
Current Ratio 1.13 1.08 ⚠️ Borderline
Cash £173,400 £78,207 ▲▲ ⚠️ Director-funded
Retained Earnings £26,075 £49,312 ▼▼ ⚠️ Declining
Total Liabilities £178,331 £131,875 ▲▲ ⚠️ Increasing
Investment Value £0 £40,000 ▼▼▼ ❌ Written off

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 21 August 2026